PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | -93.3% | 13,501 | -85.1% | 0.00% | – |
| Q1 2022 | $120,000 | -64.7% | 90,709 | -30.4% | 0.00% | – |
| Q4 2021 | $340,000 | -63.5% | 130,328 | -56.5% | 0.00% | -100.0% |
| Q3 2021 | $932,000 | +20.7% | 299,816 | +44.5% | 0.00% | – |
| Q2 2021 | $772,000 | +312.8% | 207,543 | +272.3% | 0.00% | – |
| Q4 2020 | $187,000 | +81.6% | 55,753 | +90.6% | 0.00% | – |
| Q3 2020 | $103,000 | -86.0% | 29,252 | -81.7% | 0.00% | -100.0% |
| Q2 2020 | $734,000 | +125.2% | 159,467 | +62.0% | 0.00% | 0.0% |
| Q1 2020 | $326,000 | +30.4% | 98,442 | +63.7% | 0.00% | – |
| Q3 2019 | $250,000 | -78.4% | 60,146 | -50.7% | 0.00% | -100.0% |
| Q1 2019 | $1,160,000 | +182.2% | 121,979 | -8.3% | 0.00% | +100.0% |
| Q4 2018 | $411,000 | – | 133,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
| NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
| DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
| Platform Technology Partners | 141,025 | $474,000 | 0.23% |
| Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
| Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
| Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |